Search

everythinglearnresearchcommunity

for

Search:↓

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Alopecia areata severity and symptoms vary by race and ethnicity.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Common skin conditions can greatly affect a person's mental health and social life.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Patients with alopecia areata prefer effective, safe, and convenient treatments, especially topical ones.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

Compound glycyrrhizin with conventional treatments is effective and safe for hair regrowth in alopecia areata.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

Trichobiolight effectively treats hair loss with 82.5% success.

Acne in dark skin is influenced by environmental factors and can lead to hyperpigmentation, with various treatment options available.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

De nouvelles thérapies promettent de mieux traiter la perte de cheveux due à l'alopécie androgénétique.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Ergonomic practices can reduce musculoskeletal issues for Indian plastic surgeons.

Hair loss affects self-esteem and quality of life; treatments can help.

Low-Level Light Therapy is effective for skin rejuvenation, wound healing, and hair growth, with mild side effects.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

New treatment effectively reverses hair thinning in most patients with mild side effects.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

Early diagnosis and a multidisciplinary approach are crucial for children with Trichothiodystrophy and hidden learning disorders.